Cargando…
Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1)
Myotonic dystrophy type 1 (DM1), commonly known as Steinert’s disease (OMIM #160900), is the most common muscular dystrophy among adults, caused by an unstable expansion of a CTG trinucleotide repeat in the 3′ untranslated region (UTR) of DMPK. Besides skeletal muscle, central nervous system (CNS) i...
Autores principales: | Rossi, Salvatore, Silvestri, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917343/ https://www.ncbi.nlm.nih.gov/pubmed/36768526 http://dx.doi.org/10.3390/ijms24032204 |
Ejemplares similares
-
Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1)
por: Nicoletti, Tommaso F., et al.
Publicado: (2022) -
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials
por: Garibaldi, Matteo, et al.
Publicado: (2021) -
Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1
por: Simoncini, Costanza, et al.
Publicado: (2020) -
Delay of EGF-Stimulated EGFR Degradation in Myotonic Dystrophy Type 1 (DM1)
por: Alegre-Cortés, Eva, et al.
Publicado: (2022) -
Cell type-specific abnormalities of central nervous system in myotonic dystrophy type 1
por: Nakamori, Masayuki, et al.
Publicado: (2022)